StonvexLoading…
StonvexStonvexStonvexCore line items from ABUS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $179.13M | $14.08M | $13.03M | $12.50M |
Operating Income | $168.91M | $-38.16M | $-32.87M | $-24.21M |
Net Income | $169.69M | $-33.50M | $-29.75M | $2.52M |
EPS (Diluted) | $0.87 | $-0.17 | $-0.16 | $-0.12 |
Total Assets | $277.16M | $94.62M | $97.71M | $103.27M |
Total Liabilities | $16.99M | $18.04M | $20.31M | $20.29M |
Cash & Equivalents | $23.71M | $18.01M | $22.41M | $37.41M |
Free Cash Flow OCF − CapEx | Not available | $-39.64M | $-34.96M | $-29.14M |
Shares Outstanding | 196.95M | 192.53M | 191.95M | 191.64M |